Overview

AlloMap: The Standard of Care for Managing Heart Transplant Recipients

Whether you are getting your first AlloMap® test or AlloMap is already part of your post-transplant care, this site provides general information about AlloMap and how it benefits your post-transplant care.

Join our community to receive the latest information on CareDx® and AlloMap

JOIN NOW

AlloMap is widely used and accepted

Since 2005, CareDx has made a number of achievements with AlloMap. In the last ten years there are over:

0

patient results

0

patients managed

0

insurance companies covering the test

0

transplant centers utilizing AlloMap

In addition, AlloMap has been included in the International Society of Heart and Lung Transplantation (ISHLT) guidelines since 2008.1

The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, education and advocacy.2

References:

  1. Costanzo MR, Dipchand A, Starling RC, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914-956.
  2. http://www.ishlt.org/guidelines/